FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug

Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making it the first FDA-sanctioned imaging agent for glioma, the most common form of brain cancer. …